Research Article

Hemp Waste-Derived Activated Carbon for Capecitabine Removal: Kinetic and Isothermal Insights

Volume: 10 Number: 2 May 1, 2026

Hemp Waste-Derived Activated Carbon for Capecitabine Removal: Kinetic and Isothermal Insights

Abstract

Capecitabine (CTN) is a widely used oral chemotherapeutic agent frequently detected in hospital effluents and aquatic environments, where it poses serious ecological and toxicological risks. In this study, a high surface area activated carbon derived from hemp waste-derived activated carbon waste was synthesized and evaluated for CTN removal from aqueous solutions. Under optimized conditions (adsorbent dose: 20 mg/50 mL; pH: 7.0; initial CTN concentration: 30 mg/L; contact time: 45 min; temperature: 293 K), a maximum removal efficiency of 99.12% was achieved. Kinetic analysis revealed that the adsorption process followed the pseudo second order model (R² = 0.999; RMSE and MAE minimized), indicating that surface interactions governed the adsorption rate. Equilibrium data were best described by the Langmuir isotherm model (R² = 0.9999), with a maximum adsorption capacity of 167.24 mg/g, confirming monolayer adsorption on a homogeneous surface. Thermodynamic parameters (ΔG° = −11.05 to −15.20 kJ/mol, ΔH° = +47.12 kJ/mol, ΔS° = +197.91 J/mol·K) demonstrated that the process is spontaneous, endothermic, and entropy driven, with improved adsorption at elevated temperatures. These results highlight hemp waste-derived activated carbon waste–derived activated carbon as a sustainable, low cost, and highly effective adsorbent for the removal of capecitabine from aqueous environments.

Keywords

References

  1. Kümmerer, K. (2009). The presence of pharmaceuticals in the environment due to human use – present knowledge and future challenges. Journal of Environmental Management, 90(8), 2354–2366. https://doi.org/10.1016/j.jenvman.2009.01.023
  2. Beek, T., Weber, F.-A., Bergmann, A., Hickmann, S., Ebert, I., Hein, A., & Küster, A. (2016). Pharmaceuticals in the environment—Global occurrences and perspectives. Environmental Toxicology and Chemistry, 35(4), 823–835. https://doi.org/10.1002/etc.3339
  3. Verlicchi, P., Al Aukidy, M., & Zambello, E. (2012). Occurrence of pharmaceutical compounds in urban wastewater: Removal, mass load and environmental risk. Science of the Total Environment, 429, 123–155. https://doi.org/10.1016/j.scitotenv.2012.04.028
  4. Besse, J.-P., & Garric, J. (2008). Human pharmaceuticals in surface waters: Implementation of a prioritization methodology and application to the French situation. Toxicology Letters, 176(2), 104–123. https://doi.org/10.1016/j.toxlet.2007.10.005
  5. Fent, K., Weston, A. A., & Caminada, D. (2006). Ecotoxicology of human pharmaceuticals. Aquatic Toxicology, 76(2), 122–159. https://doi.org/10.1016/j.aquatox.2005.09.009
  6. Santos, L. H. M. L. M., Araújo, A. N., Fachini, A., Pena, A., Delerue-Matos, C., & Montenegro, M. C. B. S. M. (2010). Ecotoxicological aspects related to the presence of pharmaceuticals in the aquatic environment. Journal of Hazardous Materials, 175(1–3), 45–95. https://doi.org/10.1016/j.jhazmat.2009.10.10
  7. Verlicchi, P., Galletti, A., Petrovic, M., & Barceló, D. (2010). Hospital effluents as a source of emerging pollutants: An overview of micropollutants and sustainable treatment options. Science of the Total Environment, 408(19), 5140–5151. https://doi.org/10.1016/j.scitotenv.2010.07.005
  8. Al Aukidy, M., Verlicchi, P., & Voulvoulis, N. (2014). A framework for the assessment of the environmental risk posed by pharmaceuticals originating from hospital effluents. Science of the Total Environment, 493, 54–64. https://doi.org/10.1016/j.scitotenv.2014.05.128

Details

Primary Language

English

Subjects

Environmental and Sustainable Processes

Journal Section

Research Article

Publication Date

May 1, 2026

Submission Date

November 8, 2025

Acceptance Date

January 28, 2026

Published in Issue

Year 2026 Volume: 10 Number: 2

APA
Bulduk, İ., Tokgöz, A., & Karahan, M. Y. (2026). Hemp Waste-Derived Activated Carbon for Capecitabine Removal: Kinetic and Isothermal Insights. Turkish Journal of Engineering, 10(2), 521-533. https://doi.org/10.31127/tuje.1820194
AMA
1.Bulduk İ, Tokgöz A, Karahan MY. Hemp Waste-Derived Activated Carbon for Capecitabine Removal: Kinetic and Isothermal Insights. TUJE. 2026;10(2):521-533. doi:10.31127/tuje.1820194
Chicago
Bulduk, İbrahim, Ayşin Tokgöz, and Mesut Yılmaz Karahan. 2026. “Hemp Waste-Derived Activated Carbon for Capecitabine Removal: Kinetic and Isothermal Insights”. Turkish Journal of Engineering 10 (2): 521-33. https://doi.org/10.31127/tuje.1820194.
EndNote
Bulduk İ, Tokgöz A, Karahan MY (May 1, 2026) Hemp Waste-Derived Activated Carbon for Capecitabine Removal: Kinetic and Isothermal Insights. Turkish Journal of Engineering 10 2 521–533.
IEEE
[1]İ. Bulduk, A. Tokgöz, and M. Y. Karahan, “Hemp Waste-Derived Activated Carbon for Capecitabine Removal: Kinetic and Isothermal Insights”, TUJE, vol. 10, no. 2, pp. 521–533, May 2026, doi: 10.31127/tuje.1820194.
ISNAD
Bulduk, İbrahim - Tokgöz, Ayşin - Karahan, Mesut Yılmaz. “Hemp Waste-Derived Activated Carbon for Capecitabine Removal: Kinetic and Isothermal Insights”. Turkish Journal of Engineering 10/2 (May 1, 2026): 521-533. https://doi.org/10.31127/tuje.1820194.
JAMA
1.Bulduk İ, Tokgöz A, Karahan MY. Hemp Waste-Derived Activated Carbon for Capecitabine Removal: Kinetic and Isothermal Insights. TUJE. 2026;10:521–533.
MLA
Bulduk, İbrahim, et al. “Hemp Waste-Derived Activated Carbon for Capecitabine Removal: Kinetic and Isothermal Insights”. Turkish Journal of Engineering, vol. 10, no. 2, May 2026, pp. 521-33, doi:10.31127/tuje.1820194.
Vancouver
1.İbrahim Bulduk, Ayşin Tokgöz, Mesut Yılmaz Karahan. Hemp Waste-Derived Activated Carbon for Capecitabine Removal: Kinetic and Isothermal Insights. TUJE. 2026 May 1;10(2):521-33. doi:10.31127/tuje.1820194
Flag Counter